| Dr Jonathan Gaston, DO | |
|
3333 2nd Ave N Ste 240, Billings, MT 59101-2033 | |
| (406) 248-3290 | |
| Not Available |
| Full Name | Dr Jonathan Gaston |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 3333 2nd Ave N Ste 240, Billings, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659639409 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 99579 (Montana) | Secondary |
| 207L00000X | Anesthesiology | DR.0067566 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bozeman Health Deaconess Hospital | Bozeman, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gallatin Valley Anesthesia Associates Pc | 1456372523 | 32 |
| Us Anesthesia Partners Of Colorado Inc | 6002072055 | 570 |
News Archive
What a difference a spray makes when it comes to effectively absorbing key nutrients, say health pioneers BetterYou following the BBC's 'The Truth About Healthy Eating' programme which aired last week (2 June).
People who feel in control of their lives and who find purpose and meaning in life are less likely to have anxiety disorders even when going through the toughest times, according to a study led by the University of Cambridge.
Janus Biotherapeutics today announced that they have entered into a collaboration with Roche for the development of a small molecule toll-like receptor (TLR) inhibitor with the potential to address several autoimmune diseases. TLRs are an important class of proteins that play a key role in the innate immune system.
Building on earlier work in designing chimeric human-simian immunodeficiency viruses (SHIVs) that serve as a model of HIV infection of humans, George M. Shaw, MD, PhD, a professor of Hematology/Oncology and Microbiology in the Perelman School of Medicine at the University of Pennsylvania, has received $16.3 million over five years from the National Institute of Allergy and Infectious Diseases to develop a long-sought-after HIV vaccine.
Quanta Fluid Solutions Ltd, a pioneering developer of advanced haemodialysis systems, announces it has received an Invention for Innovation (i4i) award worth £1.85 million from the National Institute for Health Research - the research arm of the NHS - to develop a new product concept for nocturnal haemodialysis.
› Verified 2 days ago
| Entity Name | Gallatin Valley Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336165182 PECOS PAC ID: 1456372523 Enrollment ID: O20051216000229 |
News Archive
What a difference a spray makes when it comes to effectively absorbing key nutrients, say health pioneers BetterYou following the BBC's 'The Truth About Healthy Eating' programme which aired last week (2 June).
People who feel in control of their lives and who find purpose and meaning in life are less likely to have anxiety disorders even when going through the toughest times, according to a study led by the University of Cambridge.
Janus Biotherapeutics today announced that they have entered into a collaboration with Roche for the development of a small molecule toll-like receptor (TLR) inhibitor with the potential to address several autoimmune diseases. TLRs are an important class of proteins that play a key role in the innate immune system.
Building on earlier work in designing chimeric human-simian immunodeficiency viruses (SHIVs) that serve as a model of HIV infection of humans, George M. Shaw, MD, PhD, a professor of Hematology/Oncology and Microbiology in the Perelman School of Medicine at the University of Pennsylvania, has received $16.3 million over five years from the National Institute of Allergy and Infectious Diseases to develop a long-sought-after HIV vaccine.
Quanta Fluid Solutions Ltd, a pioneering developer of advanced haemodialysis systems, announces it has received an Invention for Innovation (i4i) award worth £1.85 million from the National Institute for Health Research - the research arm of the NHS - to develop a new product concept for nocturnal haemodialysis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Gaston, DO Po Box 840862, Dallas, TX 75284-0862 Ph: (303) 377-7638 | Dr Jonathan Gaston, DO 3333 2nd Ave N Ste 240, Billings, MT 59101-2033 Ph: (406) 248-3290 |
News Archive
What a difference a spray makes when it comes to effectively absorbing key nutrients, say health pioneers BetterYou following the BBC's 'The Truth About Healthy Eating' programme which aired last week (2 June).
People who feel in control of their lives and who find purpose and meaning in life are less likely to have anxiety disorders even when going through the toughest times, according to a study led by the University of Cambridge.
Janus Biotherapeutics today announced that they have entered into a collaboration with Roche for the development of a small molecule toll-like receptor (TLR) inhibitor with the potential to address several autoimmune diseases. TLRs are an important class of proteins that play a key role in the innate immune system.
Building on earlier work in designing chimeric human-simian immunodeficiency viruses (SHIVs) that serve as a model of HIV infection of humans, George M. Shaw, MD, PhD, a professor of Hematology/Oncology and Microbiology in the Perelman School of Medicine at the University of Pennsylvania, has received $16.3 million over five years from the National Institute of Allergy and Infectious Diseases to develop a long-sought-after HIV vaccine.
Quanta Fluid Solutions Ltd, a pioneering developer of advanced haemodialysis systems, announces it has received an Invention for Innovation (i4i) award worth £1.85 million from the National Institute for Health Research - the research arm of the NHS - to develop a new product concept for nocturnal haemodialysis.
› Verified 2 days ago
Tysen Trujillo, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N Ste 205w, Billings, MT 59101 Phone: 406-254-0704 | |
Dr. Debra Jones, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-254-0707 Fax: 406-254-0709 | |
Dr. Cory Pickens, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-254-0707 Fax: 406-254-0709 | |
Dr. Kert Christensen, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-254-0707 Fax: 406-254-0709 | |
Patrick J Duey, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-896-2447 | |
Matthew Wysong Sherrod, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N Ste 205w, Billings, MT 59101 Phone: 817-995-6359 | |
Dr. Charles Aragon, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-254-0707 Fax: 406-254-0709 |